P

Peter Sizeland

Waikato Hospital

Publishes on Metabolism and Genetic Disorders, Renal Diseases and Glomerulopathies, Renal function and acid-base balance. 16 papers and 834 citations.

16Publications
834Total Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Anemia and Angiotensin-Converting Enzyme Inhibition in Renal Transplant Recipients
Peter Sizeland, Ross R. Bailey, Kelvin L. Lynn et al.|Journal of Cardiovascular Pharmacology|1990
Cited by 31

The renin-angiotensin system has been shown to have an effect on erythropoietin synthesis and hemoglobin concentration. We present a retrospective study of stable renal transplant recipients who received an angiotensin-converting enzyme (ACE) inhibitor as treatment of hypertension. Fifteen patients were eligible, with a mean hemoglobin concentration of 130.7 +/- 22.7 g/L (SD). Within 6 months of ACE-inhibitor therapy, the mean hemoglobin had fallen significantly to 110.5 +/- 23.2 g/L (p less than 0.001). No parallel change in leukocyte or platelet counts was evident. Prospective studies are needed to clarify the effect of inhibition of the renin-angiotensin system on erythropoietin synthesis and release.